Equities

Fuji Pharma Co Ltd

Fuji Pharma Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)1,485.00
  • Today's Change27.00 / 1.85%
  • Shares traded88.10k
  • 1 Year change+30.61%
  • Beta0.7882
Data delayed at least 20 minutes, as of May 31 2024 07:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Fuji Pharma Co., Ltd. is a Japan-based company mainly engaged in the manufacture and sale of medical products. The Company is engaged in the manufacture and sale of hormone medicines for obstetrics and gynecology department, as well as injectable drugs for radiological department such as radiopaque dye for urinary tracts and blood vessels through its branches. In addition, the Company purchases its main pharmaceutical ingredients from its main parent company.

  • Revenue in JPY (TTM)43.05bn
  • Net income in JPY5.92bn
  • Incorporated1965
  • Employees1.62k
  • Location
    Fuji Pharma Co Ltd5-7, Samban-cho6F, Seito Kaikan,CHIYODA-KU 102-0075JapanJPN
  • Phone+81 335563344
  • Fax+81 335564455
  • Websitehttps://www.fujipharma.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
TAIKO PHARMACEUTICAL CO LTD6.33bn-2.90bn18.63bn208.00--2.49--2.94-58.49-58.49129.20148.040.4622.043.4430,432,690.00-21.14---26.00--44.27---45.75--2.92--0.2811--21.43--26.23------
Astena Holdings Co Ltd52.63bn1.62bn19.79bn1.40k11.790.66865.150.376140.9840.981,332.61722.460.81273.312.7637,482,540.002.492.494.444.4432.2725.333.062.320.8713--0.351744.924.73-2.85100.61-3.8538.5411.38
Medical Data Vision Co Ltd6.25bn688.02m21.25bn262.0029.485.0928.113.4018.0118.01163.57104.341.15282.077.8423,847,790.0012.1816.1617.0120.8877.4381.9010.5515.522.7213.480.0019.985.1512.4012.4869.75-23.95--
Fuso Pharmaceutical Industries Ltd55.41bn1.38bn21.73bn1.31k14.390.53587.580.3922159.77159.776,435.264,290.490.74743.122.43--1.861.913.063.0924.9826.922.492.691.0454.560.257641.178.613.76-14.219.029.13-2.64
Pharma Foods International Co., Ltd.65.08bn4.76bn25.47bn670.005.302.674.740.3914165.17165.172,257.80327.801.842.2212.7197,135,820.0013.448.4048.1219.2079.8981.347.323.850.844991.330.683928.2613.9453.90923.8057.9251.63--
Koa Shoji Holdings Co Ltd22.67bn2.87bn28.41bn297.009.901.257.931.2572.4572.45572.11573.530.78785.562.6276,317,420.009.987.9112.089.9329.9528.7412.6610.483.8636.550.114219.648.358.2713.9029.60-21.2615.52
StemRIM Inc2.35bn179.40m28.48bn44.00135.252.90--12.12-0.1097-0.109737.43159.710.2453----53,409,090.001.87-6.711.89-6.83----7.63-45.8078.90652.720.00--10,128.0663.68108.64------
Mizuho Medy Co Ltd11.34bn4.00bn32.77bn180.008.202.147.822.89419.74419.741,190.621,607.770.64841.872.9962,999,830.0022.8631.4626.2339.7873.4174.8535.2533.646.41--0.0034.83-37.4911.34-51.8532.64-17.7432.85
SanBio Co Ltd0.00-2.64bn34.73bn29.00--12.31-----40.50-40.500.0041.110.00----0.00-43.74-42.00-52.38-48.88-------4,790.72----0.1923------52.44--53.94--
Daito Pharmaceutical Co Ltd45.19bn3.28bn34.94bn1.01k10.710.67215.140.7732207.85207.852,864.813,311.810.61931.812.6544,701,280.004.356.995.649.2921.3822.717.038.831.15--0.123117.083.772.49-22.883.437.4812.70
Fuji Pharma Co Ltd43.05bn5.92bn36.76bn1.62k6.100.81943.990.8538243.57243.571,771.381,812.380.50711.343.2126,558,910.006.974.1010.565.5839.7842.4113.757.550.5895--0.382631.1715.421.5227.410.370919.045.73
Cuorips Inc23.10m-632.18m40.08bn46.00--6.69--1,734.90-86.04-86.043.14752.260.00474.6617.57---12.94---13.30--41.69---2,736.49--33.80-------39.65---39.84------
Seikagaku Corp36.21bn2.19bn44.71bn976.0019.640.59411.481.2340.0840.08663.801,324.810.46012.065.02--2.780.42613.050.467846.6054.186.040.98144.47--0.0055415.528.244.99-2.24-0.522430.280.00
Data as of May 31 2024. Currency figures normalised to Fuji Pharma Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

9.18%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 09 May 2024526.12k2.13%
Nomura Asset Management Co., Ltd.as of 30 Apr 2024452.90k1.83%
Dimensional Fund Advisors LPas of 09 May 2024328.11k1.33%
Norges Bank Investment Managementas of 31 Dec 2023261.30k1.06%
Nikko Asset Management Co., Ltd.as of 10 May 2024218.60k0.88%
Daiwa Asset Management Co. Ltd.as of 29 Mar 2024206.70k0.84%
Mitsubishi UFJ Asset Management Co., Ltd.as of 10 May 202491.20k0.37%
Mellon Investments Corp.as of 09 May 202488.90k0.36%
Samarang LLPas of 30 Jun 202255.70k0.23%
Mayr Investment Managers GmbHas of 31 Jan 202443.90k0.18%
More ▼
Data from 30 Jun 2022 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.